Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF‐β and PD‐L1

Bintrafusp alfa, a first‐in‐class bifunctional fusion protein composed of the extracellular domain of the TGF‐βRII receptor (TGF‐β “trap”) fused to a human IgG1‐blocking PD‐L1, showed a manageable safety profile and clinical activity in phase I studies in patients with heavily pretreated advanced so...

Descripción completa

Detalles Bibliográficos
Autores principales: Vugmeyster, Yulia, Wilkins, Justin, Koenig, Andre, El Bawab, Samer, Dussault, Isabelle, Ojalvo, Laureen S., De Banerjee, Samrita, Klopp‐Schulze, Lena, Khandelwal, Akash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484916/
https://www.ncbi.nlm.nih.gov/pubmed/31955412
http://dx.doi.org/10.1002/cpt.1776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484916/
https://www.ncbi.nlm.nih.gov/pubmed/31955412
http://dx.doi.org/10.1002/cpt.1776

Ejemplares similares